BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 22
• 23
• 24
• 25
• 26
• 27

• Drug Development

  Merrimack Pharmaceuticals Inc. Announces Initiation Of A Phase 2 Biomarker-Selected Clinical Trial Of MM-121 In Patients With Heregulin Positive Non-Small Cell Lung Cancer

  February 19, 2015

   · 

  6 min read
• Drug Development

  Omeros Corporation’s Phase 2 OMS721 Trial Resulting in Extended Access for Compassionate Use

  February 19, 2015

   · 

  7 min read
• Business

  NewLink Genetics Announces Clinical Development Milestone Achieved With Merck & Co. For Ebola Vaccine Candidate

  February 19, 2015

   · 

  5 min read
• Pharm Country

  AXIM Biotechnologies, Inc. Announces Cosmetics Division

  February 19, 2015

   · 

  3 min read
• Business

  Kite Pharma Establishes Manufacturing Capabilities To Support Development And Commercialization Of CAR And TCR Cancer Immunotherapy Products

  February 19, 2015

   · 

  3 min read
• Bio NC

  SCYNEXIS, Inc. To Present At RBC Capital Markets 2015 Healthcare Conference

  February 19, 2015

   · 

  1 min read
• BioMidwest

  CHU de Saint-Etienne Launches Second Stereotaxis, Inc. Lab

  February 19, 2015

   · 

  5 min read
• Business

  ImmunoCellular Therapeutics, Ltd Strengthens Executive Management Team With Appointment Of Dr. Steven Swanson To Lead Stem-To-T-Cell Program

  February 19, 2015

   · 

  5 min read
• Business

  Alexza Pharmaceuticals, Inc. To Report 2014 Fourth Quarter And Year End Financial Results On Monday, March 9, 2015

  February 19, 2015

   · 

  3 min read
• Business

  Vanda Pharmaceuticals, Inc. Reports Fourth Quarter 2014 And Full Year 2014 Financial Results

  February 19, 2015

   · 

  11 min read